The regulation of nuclear factor erythroid derived 2 related factor 2 (NRF2) in the phase 2 response 2

THE REGULATION OF NUCLEAR FACTOR ERYTHROID-2 (NF-E2)-RELATED FACTOR (NRF2) IN THE PHASE RESPONSE DAPHNE WONG PEI WEN B.Sc. (Hons), NUS A THESIS SUBMITTED FOR THE DEGREE OF DOCTOR OF PHILOSOPHY DEPARTMENT OF BIOCHEMISTRY NATIONAL UNIVERSITY OF SINGAPORE 2014 Acknowledgements I am grateful to A/P Thilo Hagen, my supervisor, for the opportunity to conduct my research in his lab. My work would not have been possible without his guidance and patience. Thank you for patiently teaching me and being so understanding and helpful. I would like to thank Christine Hu Zhi-Wen for her emotional support and encouragement; as well as Chua Yee Liu, Hong Shin Yee, Michelle Fong, Dr. Tan Chia Yee, Regina Wong Wan Ju and Jessica Leck Yee Chin for making my lab experience an enjoyable one. I am grateful to Dr. Boh Boon Kim and Dr. Choo Yin Yin for providing the Keap1 plasmids. I am also grateful to the endophyte team: Tan Shi Hua, Lim Shu Ying, Lim Ee Chien, Seah Wen Hui, Christine Hu, Ng Mei Ying and Daphne Ng Hui Ping for their contribution in the endophyte project. I would also like to thank all other members of the lab, past and present, for their help and support. Last but not least, I am deeply grateful to my husband Moses Tan, my parents and my sister for their love and encouragement throughout the duration of my PhD.   ii     DECLARATION I hereby declare that the thesis is my original work and it has been written by me in its entirety. I have duly acknowledged all the sources of information which have been used in the thesis. This thesis has also not been submitted for any degree in any university previously. Daphne Wong Pei Wen 21 August 2014   iii     Table of Contents Acknowledgements ii Declaration iii Summary vii List of Tables ix List of Figures x List of Abbreviations xii 1.0 Introduction 1.1 Oxidative stress and its implications 1.1.1 The role of oxidative stress in carcinogenesis 1 1.2 Nrf2 (Nuclear factor erythroid-2 (NF-E2)-related factor 2) 1.3 The antioxidant response mechanism by Nrf2 1.4 Nrf2 Knockout Mouse Models 1.5 Regulation of Nrf2 activity 1.5.1 Post-translational modification of Nrf2 1.5.2 Degradation of Nrf2 : Keap1 and Cullin3 E3 Ubiquitin Ligase 1.5.3 Accumulation of Nrf2 : Keap1 as a sensor for electrophilic and oxidative stress 13 1.6 The role of Nrf2 inducers in cancer chemoprevention 2.0 Materials and Methods 18 2.1 Cell culture 18 2.2 DNA Transfection 18   iv     16 2.3 Plasmid constructs 19 2.4 Chemicals and inducers 19 2.5 Immunoblotting 20 2.6 Luciferase reporter assay 20 2.7 Immunoprecipitation 21 2.8 Immunoflourescence 21 2.9 Collection and processing of plants 22 2.10 Growth and isolation of endophytes 22 2.11 Molecular identification of isolated endophytes 23 2.12 Organic extraction of secondary metabolites from endophytes 23 3.0 The Induction of Phase response by Heteroaromatic Quinols 26 3.1 Introduction 26 3.2 Results 29 3.2.1 Heteroaromatic quinols increase Nrf2 protein concentrations 29 3.2.2 Heteroaromatic quinols increase Nrf2 transcriptional activation 32 3.2.3 Effect of quinol analogues on Nrf2 transcriptional activation when Nrf2 ubiquitination is prevented 35 3.2.4 PMX290 markedly increases the interaction of Keap1 with Cullin3 39 3.2.5 PMX290 increases Keap1 autoubiquitination 42 3.2.6 Effect of PMX290 on Keap1-dependent nuclear shuttling of Nrf2 44 3.2.7 Effect of PMX290 is independent of cysteine 151 in Keap1 3.3 Summary 52 4.0 Activation of Nrf2 by Andrographolide 54 4.1 Introduction 54 4.2 Results 56   v     48 4.2.1 Andrographolide induces the accumulation of Nrf2 in a Keap1 cysteine 151-dependent manner           4.2.2 Andrographolide increases Nrf2 transcriptional activation 4.2.3 Effect of andrographolide on Keap1-Cullin3 interaction 56 58 60 4.2.4 Correlation between the dependency of Nrf2 inducers on cysteine 151 of Keap1 and their effect on the Keap1Cullin3 interaction 61 4.2.5 Proposed model through which Keap1 Cys151-independent Nrf2 inducer compounds inhibit Nrf2 ubiquitination 4.3 Summary 63 67 5.0 Investigating novel Nrf2 inducer compounds in endophytes 69 5.1 Introduction 69 5.2 Results 72 5.2.1 Isolation and identification of bacterial and fungal endophytes from tropical ferns and mosses 72 5.2.2 Investigating the effect of organic extracts isolated from the endophytes on Nrf2 transcriptional activation 81 5.2.3 Investigating the effect of organic extracts isolated from the endophytes on Nrf2 protein concentration 5.3 Summary 85 87 6.0 Discussion and Conclusion 89 7.0 References 95       vi     Summary The detrimental effects of oxidative stress have been linked to major diseases such as cancer and neurodegenerative diseases. Oxidative stress can be sensed by the Keap1-Nrf2 system in the cell, which triggers cytoprotection via the phase response. Nrf2, a transcription factor, binds to the antioxidant response element (ARE) to induce the expression of phase detoxifying and antioxidant enzymes. Nrf2 is regulated at the protein level by Keap1, a substrate receptor for the Cullin3 E3 ubiquitin ligase. Binding of Keap1 to Nrf2 facilitates the Cullin3-mediated ubiquitination and subsequent degradation of Nrf2. We have identified a class of heteroaromatic quinol compounds as novel Nrf2 inducers. We also characterized the activation of Nrf2 by the diterpenoid andrographolide. The quinol compounds as well as andrographolide were shown to increase the Nrf2 protein concentration and Nrf2 dependent transcription. Nrf2 inducers are expected to covalently modify critical cysteine residues in Keap1, resulting in the inhibition of the Keap1-mediated Nrf2 ubiquitination and degradation. Our results show that andrographolide exerts its effect by targeting cysteine 151 in the BTB domain of Keap1. On the other hand, the quinol compounds function independently of cysteine 151 in Keap1. Interestingly, the quinol compounds markedly increased the binding between Keap1 and Cullin3 whereas andrographolide did not. Given these observations and reports on the mechanism of other Nrf2   vii     inducers, we suggest a correlation where Cys151-independent Nrf2 inducers cause an increase in the Keap1-Cullin3 interaction whereas Cys151-dependent Nrf2 inducers promote the dissociation of Keap1 from Cullin3. Thus, we propose that Cys151-independent Nrf2 inducers function via a novel mechanism that is distinct from Cys151-dependent Nrf2 inducers. The elucidation of the mechanism of action of Cys151independent Nrf2 inducers is expected to improve our understanding of the regulation of the Keap1-Cullin3 E3 ubiquitin ligase. Since secondary bioactive metabolites isolated from endophytes are a useful source of novel bioactive compounds in drug discovery, we also aimed to discover and investigate novel Nrf2 inducers from endophytes. Here, we demonstrated the presence of a potential novel Nrf2 inducer in the organic extract of a fungal endophyte, Phomopsis sp The understanding of novel Nrf2 inducers would provide useful insights for the development of therapeutics against oxidative stressrelated diseases.  viii     List of Tables Table 1. List of target genes of Nrf2 based on chromatin immunoprecipitation (ChIP) analysis. Table 2. Correlation between the dependency of Nrf2 inducers on cysteine 151 of Keap1 with Keap1-Cullin3 interaction. Table 3. List of isolated fungal and bacterial endophytes.   ix     List of Figures Figure 1.1 Schematic representation of the domains and conserved regions in Keap1 and Nrf2. pg 12 Figure 1.2 Schematic representation of the binding of Keap1 to Nrf2 which targets Nrf2 for ubiquitination. pg 13 Figure 3.1 Chemical structures of PMX464, PMX290 and BW114. pg 27 Figure 3.2 Chemical reaction between PMX464 and a reactive cysteine. pg 28 Figure 3.3 Western blot analyses of the effect of the quinol compounds on Nrf2 protein. pg 31 Figure 3.4 Quinol compounds increase transcriptional activation. Nrf2 pg 34 Figure 3.5 Effect of quinol compounds when Nrf2 ubiquitination is inhibited by dnUbc12. pg 36 Figure 3.6 PMX290 may have an inhibitory effect on Nrf2 transcriptional activity. pg 38 Figure 3.7 Effect of the quinol compounds on binding of Keap1 to Nrf2, Cullin3 and Keap1 homodimerization in vivo. pg 41 Figure 3.8 Effect of PMX290 and sulforaphane on Keap1 ubiquitination in vivo. pg 44 Figure 3.9 Effect of PMX290 on Keap1-dependent nuclear shuttling of Nrf2. pg 47 Figure 3.10 Effect of PMX290 on ΔDGR Keap1-Cullin3 interaction in vivo. pg 49 Figure 3.11 Effect of PMX290 on Nrf2 protein concentration and Keap1-Cullin3 interaction when Cys151 of Keap1 is mutated. pg 51   x     required to allow the recruitment of Nrf2 into the Cullin3 E3 ubiquitin ligase complex (Wang et al., 2008). Future studies to test this mechanism would include forced-dimerization of the Keap1-Cullin3 complex. This would mimic the disruption of dynamic assembly and disassembly cycles of the Keap1-Cullin3 complex. If this mechanism is correct, the forced-dimerization assay should result in the same effects as the Cys151-independent Nrf2 inducers. In this study, we propose a model that could possibly describe the mechanism through which Cys151-independent Nrf2 inducers inhibit Nrf2 ubiquitination (as described in Section 4.2.5). We suggest that the Cys151-independent Nrf2 inducers modify cysteine residues in the IVR of Keap1 resulting in a conformational change. The conformational change could cause a disruption in binding of Keap1 at both the ETGE and DLG motifs of Nrf2, resulting in a switch from the two-site ‘hinge & latch’ binding to the one-site ‘hinge’ binding. Consequently, Nrf2 is not presented in the correct orientation and cannot be ubiquitinated and degraded, which in turn results in the accumulation of the Nrf2 protein. Normal binding assays such as immunoprecipitation assays cannot be used to detect the switch from the two-site ‘hinge & latch’ binding to the one-site ‘hinge’ binding because even if binding of Keap1 to the DLG motif is disrupted, the Nrf2 protein will remain bound to Keap1 via the high affinity ETGE site. A recent study reported the use of a quantitative Förster resonance 91         energy transfer (FRET)-based technique using multiphoton fluorescence lifetime imaging microscopy, which was able to distinguish between the two-site ‘hinge & latch’ binding and the one-site ‘hinge’ binding of Keap1 and Nrf2 in single live cells (Baird et al., 2013). Contrary to our proposed mechanism, Baird and colleagues suggested that Nrf2 inducers cause a conformational change in Keap1 resulting in the accumulation of the Keap1-Nrf2 complex in the two-site ‘hinge & latch’ conformation without the release of Nrf2. The absence of free Keap1 binding to newly synthesized Nrf2 would result in the accumulation of Nrf2. However, Baird’s study did not distinguish between Cys151-dependent and Cys151-independent Nrf2 inducers and suggested that they act via similar mechanisms. Moreover, Baird’s proposed mechanism also did not address the increase in Keap1Cullin3 interaction caused by Cys151-independent inducers, which has also been reported by other groups (Wang et al., 2008; Kansanen et al., 2011). We suggest that it may also be possible that the increase in Keap1-Cullin3 interaction caused by Cys151-independent Nrf2 inducers resulted in an inactive Keap1-Cullin3 complex conformation, which may also result in the accumulation of the Keap1-Nrf2 complex in the two-site ‘hinge & latch’ conformation without the release of Nrf2. Nevertheless, it is evident that more studies need to be carried out to understand the mechanism of action of Nrf2 inducers, particularly those that act independently from Cys151. 92         It has been established that the Keap1 protein binds to Cullin3 through its BTB domain. Our results suggest the importance of the IVR of Keap1 in its interaction with Cullin3. Some research groups have also proposed the possible involvement of the IVR of Keap1 in the interaction between Keap1 and Cullin3 (Kobayashi et al., 2004; Chauhan et al., 2013). We suggest that Cys151-independent Nrf2 inducers modify cysteine residues in the IVR of Keap1, resulting in a conformational change disrupting Keap1 function. Unfortunately, structural studies have been deemed problematic as Keap1 is highly insoluble and so far only X-ray structures of the substrate binding domain and very recently of the BTB domain (without intervening region), but not of full-length recombinant Keap1 protein have been obtained (Li et al., 2004; Cleasby et al., 2014). The elucidation of the mechanism of action of Cys151independent Nrf2 inducers is expected to improve our understanding of the regulation of the Keap1-Cullin3 E3 ubiquitin ligase. Since the activation of the Nrf2 pathway confers cytoprotection against oxidative stress-associated diseases including cancer, the understanding of the involved mechanisms would aid in the design of novel chemopreventive agents and therapeutics for oxidative stress-related diseases. Our study also aimed to discover and investigate novel Nrf2 inducers from endophytes. Besides having anti-microbial properties, 93         secondary metabolites isolated from endophytes have also been shown to have antioxidant and anti-inflammatory properties (Strobel and Daisy, 2003). Hence, secondary bioactive metabolites isolated from endophytes would be a useful source of novel bioactive compounds in drug discovery. In our study, we have identified potent Nrf2-inducing properties in the dichloromethane extract (ORX 41) of Phomopsis sp., a fungal endophyte from the lamina of Dicranopteris linearis. Further testing is required to identify the exact organic component within ORX 41 that accounts for its Nrf2-inducing properties. The elucidation of the organic compounds with Nrf2inducing properties could lead to the discovery of a novel potent Nrf2 inducer. The understanding of novel Nrf2 inducers would provide useful insights for the development of therapeutics against oxidative stressrelated diseases and cancer chemoprevention. 94         7.0 References Baird, L., Llères, D., Swift, S., and Dinkova-Kostova, A. T. (2013). Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex. Proc Natl Acad Sci U S A 110, 15259-15264. Bardwell, V. J., and Treisman, R. (1994). The POZ domain: a conserved protein-protein interaction motif. Genes Dev 8, 1664-1677. Bascom-Slack, C. A., Arnold, A. E., and Strobel, S. A. (2012). IBI series winner. Student-directed discovery of the plant microbiome and its products. Science 338, 485-486. Berry, J. M., Bradshaw, T. D., Fichtner, I., Ren, R., Schwalbe, C. H., Wells, G., Chew, E. H., Stevens, M. F. G., and Westwell, A. D. (2005). Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents. J Med Chem 48, 639-644. Bigner, D. D., Bigner, S. H., Burger, P. C., Shelburne, J. D., and Friedman, H. S. (1986). Primary brain tumours in Fischer 344 rats chronically exposed to acrylonitrile in their drinking-water. Food Chem Toxicol 24, 129-137. Bloom, D. A., and Jaiswal, A. K. (2003). Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J Biol Chem 278, 44675-44682. Bradshaw, T. D., Matthews, C. S., Cookson, J., Chew, E. H., Shah, M., Bailey, K., Monks, A., Harris, E., Westwell, A. D., and Wells, G., et al. (2005). Elucidation of thioredoxin as a molecular target for antitumor quinols. Cancer Res 65, 3911-3919. 95         Chan, K., Lu, R., Chang, J. C., and Kan, Y. W. (1996). NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci U S A 93, 13943-13948. Chang, C. F., Cho, S., and Wang, J. (2014). (-)-Epicatechin protects hemorrhagic brain via synergistic Nrf2 pathways. Annals of clinical and translational neurology 1, 258-271. Chapla, V. M., Zeraik, M. L., Ximenes, V. F., Zanardi, L. M., Lopes, M. N., Cavalheiro, A. J., Silva, D. H. S., Young, M. C. M., Fonseca, L. M. D., and Bolzani, V. S., et al. (2014). Bioactive secondary metabolites from Phomopsis sp., an endophytic fungus from Senna spectabilis. Molecules 19, 6597-6608. Chauhan, N., Chaunsali, L., Deshmukh, P., and Padmanabhan, B. (2013). Analysis of dimerization of BTB-IVR domains of Keap1 and its interaction with Cul3, by molecular modeling. Bioinformation 9, 450455. Chew, E. H., Lu, J., Bradshaw, T. D., and Holmgren, A. (2008). Thioredoxin reductase inhibition by antitumor quinols: a quinol pharmacophore effect correlating to antiproliferative activity. FASEB J 22, 2072-2083. Chew, E. H., Matthews, C. S., Zhang, J., McCarroll, A. J., Hagen, T., Stevens, M. F. G., Westwell, A. D., and Bradshaw, T. D. (2006). Antitumor quinols: role of glutathione in modulating quinol-induced apoptosis and identification of putative cellular protein targets. Biochem Biophys Res Commun 346, 242-251. Chew, E. H., Poobalasingam, T., Hawkey, C. J., and Hagen, T. (2007). Characterization of cullin-based E3 ubiquitin ligases in intact mammalian cells--evidence for cullin dimerization. Cell Signal 19, 10711080. Chorley, B. N., Campbell, M. R., Wang, X., Karaca, M., Sambandan, D., Bangura, F., Xue, P., Pi, J., Kleeberger, S. R., and Bell, D. A. (2012). Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha. Nucleic Acids Res 40, 74167429. 96         Cleasby, A., Yon, J., Day, P. J., Richardson, C., Tickle, I. J., Williams, P. A., Callahan, J. F., Carr, R., Concha, N., and Kerns, J. K., et al. (2014). Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO. PloS one 9, e98896. Cooper-Driver, G. (1977). Chemical evidence for separating the psilotaceae from the filicales. Science 198, 1260-1262. Cullings, K. W., and Vogler, D. R. (1998). A 5.8S nuclear ribosomal RNA gene sequence database: applications to ecology and evolution. Mol Ecol 7, 919-923. Dhakshinamoorthy, S., and Porter, A. G. (2004). Nitric oxide-induced transcriptional up-regulation of protective genes by Nrf2 via the antioxidant response element counteracts apoptosis of neuroblastoma cells. J Biol Chem 279, 20096-20107. Dinkova-Kostova, A. T., Massiah, M. A., Bozak, R. E., Hicks, R. J., and Talalay, P. (2001). Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc Natl Acad Sci U S A 98, 34043409. Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., and Talalay, P. (2002). Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci U S A 99, 11908-11913. Eggler, A. L., Small, E., Hannink, M., and Mesecar, A. D. (2009). Cul3mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1. Biochem J 422, 171-180. Embong, Z., Wan Hitam, W. H., Yean, C. Y., Rashid, N. H. A., Kamarudin, B., Abidin, S. K. Z., Osman, S., Zainuddin, Z. F., and Ravichandran, M. (2008). Specific detection of fungal pathogens by 18S rRNA gene PCR in microbial keratitis. BMC Ophthalmol 8, 7. 97         Eswani, N., Kudus, K.A., Nazre, M., Noor, A.G.A., and Ali, M. (2010). Medicinal Plant Diversity and Vegetation Analysis of Logged over Hill Forest of Tekai Tembeling Forest Reserve, Jerantut, Pahang. J. Agric. Sci. 2, 189. Fahey, J. W., Haristoy, X., Dolan, P. M., Kensler, T. W., Scholtus, I., Stephenson, K. K., Talalay, P., and Lozniewski, A. (2002). Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc Natl Acad Sci U S A 99, 7610-7615. Giudice, A., and Montella, M. (2006). Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention. Bioessays 28, 169-181. Guan, S. P., Tee, W., Ng, D. S. W., Chan, T. K., Peh, H. Y., Ho, W. E., Cheng, C., Mak, J. C., and Wong, W. S. F. (2013). Andrographolide protects against cigarette smoke-induced oxidative lung injury via augmentation of Nrf2 activity. Br J Pharmacol 168, 1707-1718. Hayes, J. D., and McMahon, M. (2001). Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett 174, 103-113. Hirotsu, Y., Katsuoka, F., Funayama, R., Nagashima, T., Nishida, Y., Nakayama, K., Engel, J. D., and Yamamoto, M. (2012). Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks. Nucleic Acids Res 40, 10228-10239. Hong, F., Freeman, M. L., and Liebler, D. C. (2005). Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane. Chem Res Toxicol 18, 19171926. Huang, H. C., Nguyen, T., and Pickett, C. B. (2000). Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. Proc Natl Acad Sci U S A 97, 12475-12480. 98         Huang, H. C., Nguyen, T., and Pickett, C. B. (2002). Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem 277, 42769-42774. Hubbs, A. F., Benkovic, S. A., Miller, D. B., O'Callaghan, J. P., Battelli, L., Schwegler-Berry, D., and Ma, Q. (2007). Vacuolar leukoencephalopathy with widespread astrogliosis in mice lacking transcription factor Nrf2. Am J Pathol 170, 2068-2076. Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., and Hatayama, I., et al. (1997). An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236, 313-322. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., and Yamamoto, M. (1999). Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the aminoterminal Neh2 domain. Genes Dev 13, 76-86. Johannsen, F. R., and Levinskas, G. J. (2002). Chronic toxicity and oncogenic dose-response effects of lifetime oral acrylonitrile exposure to Fischer 344 rats. Toxicol Lett 132, 221-247. Kansanen, E., Bonacci, G., Schopfer, F. J., Kuosmanen, S. M., Tong, K. I., Leinonen, H., Woodcock, S. R., Yamamoto, M., Carlberg, C., and Ylä-Herttuala, S., et al. (2011). Electrophilic nitro-fatty acids activate NRF2 by a KEAP1 cysteine 151-independent mechanism. J Biol Chem 286, 14019-14027. Katsuoka, F., Motohashi, H., Ishii, T., Aburatani, H., Engel, J. D., and Yamamoto, M. (2005). Genetic evidence that small maf proteins are essential for the activation of antioxidant response element-dependent genes. Mol. Cell Biol. 25, 8044-8051. Khor, T. O., Huang, M. T., Kwon, K. H., Chan, J. Y., Reddy, B. S., and Kong, A. N. (2006). Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. Cancer Res 66, 1158011584. 99         Khor, T. O., Huang, M. T., Prawan, A., Liu, Y., Hao, X., Yu, S., Cheung, W. K. L., Chan, J. Y., Reddy, B. S., and Yang, C. S., et al. (2008). Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer. Cancer prevention research (Philadelphia, Pa.) 1, 187-191. Kim, K. W., Chanpiwat, P., Hanh, H. T., Phan, K., and Sthiannopkao, S. (2011). Arsenic geochemistry of groundwater in Southeast Asia. Frontiers of medicine 5, 420-433. Kitamura, Y., Umemura, T., Kanki, K., Kodama, Y., Kitamoto, S., Saito, K., Itoh, K., Yamamoto, M., Masegi, T., and Nishikawa, A., et al. (2007). Increased susceptibility to hepatocarcinogenicity of Nrf2deficient mice exposed to 2-amino-3-methylimidazo[4,5-f]quinoline. Cancer Sci 98, 19-24. Klaunig, J. E., Xu, Y., Isenberg, J. S., Bachowski, S., Kolaja, K. L., Jiang, J., Stevenson, D. E., and Walborg, E. F. (1998). The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect 106 Suppl 1, 289-295. Kobayashi, A., Kang, M. I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., and Yamamoto, M. (2004). Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell Biol. 24, 7130-7139. Konturek, P. C., Konturek, S. J., and Brzozowski, T. (2006). Gastric cancer and Helicobacter pylori infection. J Physiol Pharmacol 57 Suppl 3, 51-65. Kumar, R. A., Sridevi, K., Kumar, N. V., Nanduri, S., and Rajagopal, S. (2004). Anticancer and immunostimulatory compounds from Andrographis paniculata. J Ethnopharmacol 92, 291-295. Li, W., and Kong, A. N. (2009). Molecular mechanisms of Nrf2mediated antioxidant response. Mol Carcinog 48, 91-104. Li, X., Zhang, D., Hannink, M., and Beamer, L. J. (2004). Crystal structure of the Kelch domain of human Keap1. J Biol Chem 279, 54750-54758. 100         Liby, K. T., and Sporn, M. B. (2012). Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease. Pharmacol Rev 64, 972-1003. Lim, J. C. W., Chan, T. K., Ng, D. S. W., Sagineedu, S. R., Stanslas, J., and Wong, W. S. F. (2012). Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer. Clin Exp Pharmacol Physiol 39, 300-310. Lyu, J. H., Lee, G. S., Kim, K. H., Kim, H. W., Cho, S. I., Jeong, S. I., Kim, H. J., Ju, Y. S., Kim, H. K., and Sadikot, R. T., et al. (2011). entkaur-16-en-19-oic Acid, isolated from the roots of Aralia continentalis, induces activation of Nrf2. J Ethnopharmacol 137, 1442-1449. Ma, Q., Battelli, L., and Hubbs, A. F. (2006). Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2. Am J Pathol 168, 1960-1974. Malhotra, D., Portales-Casamar, E., Singh, A., Srivastava, S., Arenillas, D., Happel, C., Shyr, C., Wakabayashi, N., Kensler, T. W., and Wasserman, W. W., et al. (2010). Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res 38, 5718-5734. McMahon, M., Itoh, K., Yamamoto, M., Chanas, S. A., Henderson, C. J., McLellan, L. I., Wolf, C. R., Cavin, C., and Hayes, J. D. (2001). The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res 61, 3299-3307. McMahon, M., Thomas, N., Itoh, K., Yamamoto, M., and Hayes, J. D. (2004). Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron. J Biol Chem 279, 31556-31567. 101         McMahon, M., Thomas, N., Itoh, K., Yamamoto, M., and Hayes, J. D. (2006). Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a "tethering" mechanism: a two-site interaction model for the Nrf2-Keap1 complex. J Biol Chem 281, 24756-24768. Moi, P., Chan, K., Asunis, I., Cao, A., and Kan, Y. W. (1994). Isolation of NF-E2-related factor (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci U S A 91, 9926-9930. Motohashi, H., Katsuoka, F., Engel, J. D., and Yamamoto, M. (2004). Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway. Proc Natl Acad Sci U S A 101, 6379-6384. Nair, D. N., and Padmavathy, S. (2014). Impact of endophytic microorganisms on plants, environment and humans. ScientificWorldJournal 2014, 250693. Nilsson, R. H., Kristiansson, E., Ryberg, M., Hallenberg, N., and Larsson, K. H. (2008). Intraspecific ITS variability in the kingdom fungi as expressed in the international sequence databases and its implications for molecular species identification. Evolutionary bioinformatics online 4, 193-201. Nioi, P., McMahon, M., Itoh, K., Yamamoto, M., and Hayes, J. D. (2003). Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase gene: reassessment of the ARE consensus sequence. Biochem J 374, 337348. Ramos-Gomez, M., Kwak, M. K., Dolan, P. M., Itoh, K., Yamamoto, M., Talalay, P., and Kensler, T. W. (2001). Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci U S A 98, 3410-3415. 102         Revathi, R., Muthuraja, R., Binu, Thomas, Raju, K. (2013). Ethno medicinal fern and fern-allies used by tribe Malayalis of Kolli Hills, Gayathri Teknological Publication 2(1), 1-10. Rushmore, T. H., Morton, M. R., and Pickett, C. B. (1991). The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem 266, 11632-11639. Sekhar, K. R., Rachakonda, G., and Freeman, M. L. (2010). Cysteinebased regulation of the CUL3 adaptor protein Keap1. Toxicol Appl Pharmacol 244, 21-26. Seril, D. N., Liao, J., Yang, G. Y., and Yang, C. S. (2003). Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 24, 353-362. Shen, H. M., and Ong, C. N. (1996). Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis. Mutat Res 366, 23-44. Sies, H. (1997). Oxidative stress: oxidants and antioxidants. Exp Physiol 82, 291-295. Sinha, D., Roy, S., and Roy, M. (2010). Antioxidant potential of tea reduces arsenite induced oxidative stress in Swiss albino mice. Food Chem Toxicol 48, 1032-1039. Sinha, D., and Roy, M. (2011). Antagonistic role of tea against sodium arsenite-induced oxidative DNA damage and inhibition of DNA repair in Swiss albino mice. J Environ Pathol Toxicol Oncol 30, 311-322. Stierle, A., Strobel, G., and Stierle, D. (1993). Taxol and taxane production by Taxomyces andreanae, an endophytic fungus of Pacific yew. Science 260, 214-216. Strobel, G., and Daisy, B. (2003). Bioprospecting for microbial endophytes and their natural products. Microbiol Mol Biol Rev 67, 491502. 103         Sudakin, D. L. (2003). Biopesticides. Toxicol Rev 22, 83-90. Sun, Z., Chin, Y. E., and Zhang, D. D. (2009). Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response. Mol. Cell Biol. 29, 2658-2672. Sun, Z., Huang, Z., and Zhang, D. D. (2009). Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response. PloS one 4, e6588. Sun, Z., Zhang, S., Chan, J. Y., and Zhang, D. D. (2007). Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2. Mol. Cell Biol. 27, 63346349. Suzuki, T., Motohashi, H., and Yamamoto, M. (2013). Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol Sci 34, 340346. Sykiotis, G. P., and Bohmann, D. (2010). Stress-activated cap'n'collar transcription factors in aging and human disease. Science signaling 3, re3. Thimmulappa, R. K., Mai, K. H., Srisuma, S., Kensler, T. W., Yamamoto, M., and Biswal, S. (2002). Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 62, 5196-5203. Tong, K. I., Katoh, Y., Kusunoki, H., Itoh, K., Tanaka, T., and Yamamoto, M. (2006). Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol. Cell Biol. 26, 2887-2900. Tong, K. I., Kobayashi, A., Katsuoka, F., and Yamamoto, M. (2006). Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol Chem 387, 1311-1320. 104         Trivedi, P.C. (2009). Medicinal plants: utilisation and conservation (Aavishkar Publishers, Distributors). Venugopal, R., and Jaiswal, A. K. (1996). Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc Natl Acad Sci U S A 93, 14960-14965. Wada, H., Yeh, E. T., and Kamitani, T. (2000). A dominant-negative UBC12 mutant sequesters NEDD8 and inhibits NEDD8 conjugation in vivo. J Biol Chem 275, 17008-17015. Wang, X. J., Sun, Z., Chen, W., Li, Y., Villeneuve, N. F., and Zhang, D. D. (2008). Activation of Nrf2 by arsenite and monomethylarsonous acid is independent of Keap1-C151: enhanced Keap1-Cul3 interaction. Toxicol Appl Pharmacol 230, 383-389. Wasserman, W. W., and Fahl, W. E. (1997). Functional antioxidant responsive elements. Proc Natl Acad Sci U S A 94, 5361-5366. Wee, Y.C. (2005). Ferns of the tropics (Singapore: Times EditionsMarshall Cavendish). Wells, G., Berry, J. M., Bradshaw, T. D., Burger, A. M., Seaton, A., Wang, B., Westwell, A. D., and Stevens, M. F. G. (2003). 4-Substituted 4-hydroxycyclohexa-2,5-dien-1-ones with selective activities against colon and renal cancer cell lines. J Med Chem 46, 532-541. Wong, D. P. W., Wells, G., and Hagen, T. (2010). Heteroaromatic 4arylquinols are novel inducers of nuclear factor-erythroid 2-related factor (Nrf2). Eur J Pharmacol 643, 188-194. World Health Organization (2002). WHO Monographs on Selected Medicinal Plants, 2, 12-24. Xia, Y. F., Ye, B. Q., Li, Y. D., Wang, J. G., He, X. J., Lin, X., Yao, X., Ma, D., Slungaard, A., and Hebbel, R. P., et al. (2004). Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J Immunol 173, 4207-4217. 105         Zhang, D. D., and Hannink, M. (2003). Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell Biol. 23, 8137-8151. Zhang, D. D., Lo, S. C., Cross, J. V., Templeton, D. J., and Hannink, M. (2004). Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell Biol. 24, 1094110953. Zhang, D. D., Lo, S. C., Sun, Z., Habib, G. M., Lieberman, M. W., and Hannink, M. (2005). Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway. J Biol Chem 280, 30091-30099. Zhang, Z., Cui, W., Li, G., Yuan, S., Xu, D., Hoi, M. P. M., Lin, Z., Dou, J., Han, Y., and Lee, S. M. Y. (2012). Baicalein protects against 6OHDA-induced neurotoxicity through activation of Keap1/Nrf2/HO-1 and involving PKCα and PI3K/AKT signaling pathways. J Agric Food Chem 60, 8171-8182. 106         [...]... Nterminus of the Nrf2 DNA binding domain (Figure 1.1) The name Nuclear factor erythroid- 2 (NF-E2) -related factor 2 is derived from another transcription factor p45 NFE2 (nuclear factor erythroid- derived 2) from the same CnC-bZip family Nrf2 contains a Basic Leucine Zipper Domain (bZIP domain) which mediates sequence specific DNA binding The leucine zipper is required to hold together two DNA binding... C151 E2 E2 E2 Keap1 Ub Rbx1 Cullin3 Figure 1 .2 Schematic representation of the binding of Keap1 to Nrf2 which targets Nrf2 for ubiquitination Keap1 functions as the substrate receptor of a Cullin-3-based E3 ubiquitin ligase and binds to ETGE domain and DLG domain of Nrf2 via its Kelch repeat domain The binding of Keap1 promotes transfer of ubiquitin from the E2 ubiquitin-conjugating enzyme to Nrf2, thus... exactly these modifications can affect Nrf2 ubiquitination or Nrf2 binding to the Cullin3 ubiquitin complex formation The elucidation of the mechanism through which Nrf2 is induced is expected to improve our understanding of the regulation of the Keap1Cullin3 E3 ubiquitin ligase The understanding of the involved mechanisms would aid in the design of novel chemopreventive agents and in the development of. .. located in the intervening region (IVR) between the BTB domain and Kelch repeat domains of Keap1 (Figure 1 .2) Zhang et al later narrowed down the number of reactive cysteine residues to two crucial cysteine residues: cysteine 27 3 and cysteine 28 8 in the IVR of Keap1 (Zhang and Hannink, 20 03) These authors showed that cysteine 27 3 and cysteine 28 8 are essential for Keap1-dependent ubiquitination of Nrf2 Their... for the subsequent low affinity interaction between Keap1 and the DLG site The positioning of the ‘latch’ may promote the correct orientation of the lysine residues on Nrf2 for ubiquitin binding This ‘hinge & latch’ model (Tong, Kobayashi, et al., 20 06) is a two-site binding model of Keap1 to Nrf2 and should be distinguished from a one-site ‘hinge’ binding model The one-site binding is a mere binding... the ETGE motif due to its higher affinity and does not present Nrf2 in the correct orientation for ubiquitination It has been shown that the deletion of the low affinity DLG domain, which is involved in the ‘latch’ binding in Nrf2, prevented Nrf2 degradation (McMahon et al., 20 04) Therefore, only the two-sites ‘hinge & latch’ binding model would allow Nrf2 to be ubiquitinated In summary, since Nrf2... IVR intervening region Keap1 Kelch-like ECH-associated protein 1 MAPK Mitogen-activated protein kinases NF-E2 Nuclear factor erythroid- 2 NF- κB Nuclear Factor- kappaB Nrf2 Nuclear factor erythroid- 2 (NF-E2) -related factor 2 Nqo1 NAD(P)H:quinine oxidoreductase 1   xii     PKC Protein Kinase C Rbx RING-box protein 1 SF sulforaphane tBHQ tert-butyl hydroxyquinone Ub ubiquitin     xiii     1.0 Introduction... with these two conserved motifs with different affinities The high affinity binding of Keap1 to the ETGE motif serves as a ‘hinge’ to pin down the Neh2 domain of Nrf2 to Keap1 (Tong, Kobayashi, et al., 20 06; Li and Kong, 20 09) On the other hand, Keap1 binds to the DLG domain with lower affinity and this interaction serves as a ‘latch’ It is likely that the high affinity interaction of Keap1 with the. .. acids 29 -31) and the ETGE motif (amino acids 79- 82) which are involved in the binding of Keap1 There are seven lysine residues between the DLG motif and the ETGE motif which can be ubiquitinated (b) Three functional domains in Keap1: BTB domain, IVR (intervening region) and Kelch repeat domain Adapted from McMahon et al., 20 06   12     Ub Ub Ub Nrf2 ET GE KEL CH DLG Ub KELCH C288 IVR C288 C273 IVR C273... 1.3 The antioxidant response mechanism by Nrf2   4     Early evidences suggesting the role of Nrf2 in the antioxidant response mechanism originated from studies showing the upregulation of NAD(P)H:quinine oxidoreductase 1 (NQO1) (an enzyme involved in maintaining redox balance in the cell) by Nrf2, in response to oxidative stress from xenobiotics and electrophiles (Venugopal and Jaiswal, 1996) In this . domain at the N- terminus of the Nrf2 DNA binding domain (Figure 1.1). The name Nuclear factor erythroid- 2 (NF-E2) -related factor 2 is derived from another transcription factor p45 NFE2 (nuclear. protein 1 MAPK Mitogen-activated protein kinases NF-E2 Nuclear factor erythroid- 2 NF- κB Nuclear Factor- kappaB Nrf2 Nuclear factor erythroid- 2 (NF-E2) -related factor 2 Nqo1 NAD(P)H:quinine. THE REGULATION OF NUCLEAR FACTOR ERYTHROID- 2 (NF-E2) -RELATED FACTOR 2 (NRF2) IN THE PHASE 2 RESPONSE DAPHNE WONG PEI WEN B.Sc. (Hons), NUS A THESIS SUBMITTED